0 item $0.00

Molecular Proteomics

We explore intercellular signalling and apply advanced omics in the context of the heart and circulation

Read more

Laboratory head

Close
i Profile of author

Latest Achievements

Inaugural/past-President, Australia and New Zealand Society of Extracellular Vesicles

Top 250 Researchers in Australia, Australian Research Magazine

Helen Amelia Hains Fellow and Baker Institute Fellow

Australian Field Leader (outright) – Proteins, Proteomics, Australian Research Magazine (2026)

Chair, International Society of Extracellular Vesicles Congress (2024)

Read full biography
Professor David Greening Baker Institute Fellow
Our research seeks to understand cell signalling through nanovesicles as a therapeutic strategy and to integrate multidisciplinary technologies to understand cardiac remodelling and its repair.

 

What is proteomics?     Collaborate with us

About the Molecular Proteomics laboratory

The Molecular Proteomics laboratory is focused on understanding the molecular function of nano-sized biological extracellular vesicles (EVs) and how their intercellular signalling is important in normal cardiac physiology and disease.

Given the heart's limited regenerative capacity, developing strategies to restore lost cardiac tissue remains a critical, unmet challenge in cardiovascular medicine. Our goal is to engineer EVs to overcome limitations in their therapeutic application and identify new deliverable therapeutic targets.

What are extracellular vesicles?

Extracellular vesicles are nano-sized, cell-derived signalling mediators that package and transfer key molecular cargo to target cells. They've emerged as an innovative cell-free regenerative strategy due to their ability to deliver therapeutic cargo — offering new hope for repairing damaged hearts without traditional cell transplantation.

Research approach

Our team develops multidisciplinary strategies to define and understand the form and function of EVs, the heart as a signalling organ, and innovative proteomic technologies to understand the mechanistic underpinnings of complex biology.

The advanced molecular and micro-functional assay approaches developed in our laboratory have identified novel regulators of the secretome — cell-derived secreted factors — and EV biology. We integrate advanced mass spectrometry-based proteomics to decipher key regulators and networks remodelled in various models of cardiovascular disease.

Multi-omics for cardiac health

We apply multi-omics approaches to understand complex molecular changes, including protein modifications, in heart health and as therapeutic strategies in vascular and cardiac disease. These innovations have led to preclinical and clinical utility, including commercialisation, with significant engagement with national and international industry networks in biotechnology, proteomics and regenerative medicine fields.

Our integrated expertise

The Molecular Proteomics team incorporates advanced proteomics, systems biology, cell signalling, molecular biology, nanomaterials, nanobiotechnology, regenerative cell biology and expertise in molecular therapies. Our goal is to identify new deliverable therapeutic targets and therapeutic strategies to understand vascular and cardiac disease, and ultimately facilitate effective engineered approaches for next-generation cell-free cardiac therapy.

Join our team

We offer projects across these research areas, with specific topics designed to match the interests and skills of each candidate. As a prospective student, you'll join a successful multidisciplinary research team of molecular biologists, cell biologists, proteomics experts, nanomaterials specialists, extracellular vesicle researchers and clinical scientists.

You'll gain experience in:

  • Quantitative omics technologies, including proteomics.
  • Cardiovascular disease research.
  • Cell biology, molecular biology and biochemistry.
  • Extracellular vesicle biology and therapeutics.
  • Nanomaterials and nanobiotechnology.

University placements

We have university placements available through La Trobe University and the University of Melbourne. Contact us for more information about joining our team.

 

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more